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From investigations of the adenylate cyclase sys- 
tems in several membranes it is now clear that the sys- 
tem consists of at least 3 protein components: the 
hormone receptor (R), the guanine nucleotide regula- 
tory component (N), and the catalytic unit (C) [l-5]. 
Despite the existence of these 3 types of units in all 
systems tudied so far, the nucleotide component 
shows several functional differences in different ypes 
of plasma membr~es [f&7]. For example, the adenyl- 
ate cyclase system of the turkey erythrocyte plasma 
membranes, in contrast o the liver and fat cell plasma 
membranes, displays the unusual property of binding 
the guanine nucleotide GDP tightly [6], presumably 
to the N component. Possibly as a result of this tight 
binding, Gpp(NH)p, which activates many adenylate 
cyclase systems rapidly and completely, activates 
turkey erythrocyte membrane adenylate cyclase poorly 
and then only with a lag of several hours. If the acti- 
vation of the catalytic unit were limited by the stoi- 
chiometry of the N unit relative to C, a lag in acti- 
vation would be expected. A way of testing this prop- 
osition would be to add exogenous nucleotide unit 
to the turkey erythrocyte membrane and to examine 
the functional consequences. Three questions need to 
be answered: 
(i) Would the added N unit be capable of functional 
linkage with the catalytic unit? 
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(ii) Could the tight binding of GDP, an inhibitor of 
Gpp(NH)p activation, be reversed by the addition? 
(iii) Would the added N unit influence the guanine 
nucleotide xchange r action, which is specifically 
promoted by the fl-adrenergic receptor [8,9]? 
In order to answer these questions it was necessary 
to choose a source for donor N and a method for com- 
plementation. Possibilities for these were suggested 
by recent experiments [ 7,101 with the human eryth- 
rocyte membrane which contains N as judged by the 
fo~owing criteria: 
(i) It reconstitutes both Gpp~H)p and fluoride re- 
sponses with cyc-. 
(ii) Labeling with cholera toxin and [cx-~~P]NAD 
leads to the incorporation of label into a single 
band ofM, 42 000 which is thought o represent 
the N unit. 
(iii) Toxin modification also leads to a diminution of 
fluoride response and an enhancement of GTP 
activation when the modified human erythrocyte 
membrane iscomplemented with cyc-. 
It can also be shown that the human erythrocyte 
membrane contains the N units in an amount equiva- 
lent to that found in other membranes but by contrast 
contains very little adenylate cyclase catalytic activity 
or P-adrenergic receptor [IO]. The mode of comple- 
mentation is also suggested by these experiments in
which functional linkage was obtained merely by 
mixing vesicles in the presence of activating ligands, 
In these experiments we show that the human 
erythrocyte membrane upon addition to the turkey 
erythrocyte membrane causes an increase in Gpp(NH)p 
activation. The functional linkage between donor N 
and the acceptor C occurs without the release of GDP 
from the recipient membrane N unit and without 
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participation of the hormone promoted guanine nu- 
cleotide exchange reaction. 
2. Experimental 
ATP synthesized from adenosine was purchased 
from Sigma; [(Y-~‘P] ATP was purchased from ICN. 
Human erythrocyte membranes were prepared and 
the adenylate cyclase assayed as in [6,12]. Treatment 
of membranes with cholera toxin was by a modifica- 
tion [lo] of the method in [ 131. Protein measure- 
ments were following [ 141. The complementation 
assay was done by the general method in [lo], except 
that here we used turkey erythrocyte membranes as 
acceptor and human erythrocyte membranes as N 
component donor. Functional interaction occurred 
upon mixing, as described below. 
3. Results 
Fig.1 shows the time course of Gpp(NH)p-activa- 
tion of adenylate cyclase for the turkey erythrocyte 
membrane alone and in the presence of a saturating 
amount of the human erythrocyte membrane. In- 
creased concentrations of the donor human erythro- 
cyte membrane caused increased activation, and the 
process was saturable. Under the conditions used, 
saturation of the response occurs at a ratio of 3.3 for 
human erythrocyte protein to turkey erythrocyte 
protein (not shown). This value reflects a contribution 
relating to the relative amounts of cyclase components 
in these two membranes [lo]. The lag observed in ap- 
proaching steady state is characteristic of the com- 
plementation process when it involves only vesicle 
mixing, and is thought to represent he time required 
for functional linkage between components [IO]. 
Here, steady state of complementation is reached in 
-10 min. 
The dose-response for activation by Gpp(NH)p is 
shown in fig.2. Because of the complex nature of the 
assay, full time courses are shown. The half-maximal 
concentration for Gpp(NH)p activation was 2 PM. 
At these concentrations, no activation by Gpp(NH)p 
of the acceptor turkey erythrocyte membrane was 
observed, in the absence of the hormone. This con- 
centration is close to the value obtained for the acti- 
vation process in other membranes [3]. 
These results suggested that the nucleotide com- 
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Fig.1. Turkey erthyrocyte membranes (*), human erythro- 
cyte membranes (o), or both turkey and human erythrocyte 
membranes (0) were diluted at 0°C to form a suspension with 
the following composition: 0.17 mg/ml of turkey erythro- 
cyte membrane protein; 1.07 mg/ml of human erythrocyte 
membrane protein; [or-“P]ATP (100-500 cpm/pmol); 0.1 
mM ATP; 10 mM MgCl,; 0.1 mM Gpp(NH)p; 1mM DTT; 5 
mM creatine phosphate; 33 units/ml of creatine phospho- 
kinase; 10 mM Tris-HCl pH 7.5. The mixture was incubated 
at 30°C; at the times indicated, 0.100 ml aliquots were with- 
drawn into ‘stopping solution’ and cyclic AMP isolated [ 121. 
ponent in the donor human erythrocyte membrane 
became functionally coupled to the catalytic unit in 
the turkey erythrocyte membrane. As a further test, 
the donor membrane was treated with cholera toxin 
and NAD, prior to addition to the turkey erythrocyte 
membrane. When the control membrane is added to 
the acceptor turkey erythrocyte membrane, some GTP 
activation is indeed conferred but this is well below the 
levels obtained with Gpp(NH)p as the activating ligand. 
As seen in table 1, after modification with cholera 
toxin, the GTP response of the system was magnified. 
A variety of other membranes containing complete 
adenylate cyclase systems show similar functional re- 
sponses to cholera toxin [ 161. Thus, the effects in com- 
plementation reported here are indeed due to the 
cyclase-related guanine nucleotide component in the 
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Fig.2. Human erythrocyte and turkey erythrocyte mem- 
branes were mixed (6.6:1) and assayed as in tig.1, except that 
Gpp(NH)p was: none (0); lo-’ M (0); 1Om6 M (9); IO-’ M 
(A); or 1O-4 M (0). 
Table 1 
Adenylate cyclase activity [pmol . (15 min)-’ . (mg)-‘1 
Donor mem- 
branes pre- 
treated with 
NAD 
Donor mem- 
branes pre- 
treated with 
NAD and 
cholera toxin 
Turkey erythrocyte 2.7 + 0.3 2.8 * 0.3 
Human erythrocyte 0.1 f 0.2 0.1 f 0.4 
Turkey erythrocyte 
+ human erythrocyte 4.0 f 0.4 9.0 f 0.7 
Adenylate cyclase was assayed in the presence of lo-$ M 
GTP. Steady state activities were determined from time 
curves as in other experiments. The donor human erythro- 
cyte membrane was incubated without or with cholera toxin 
(64 pg/mg) as in [lo] 
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Fig.3. Human and turkey erythrocyte membranes were com- 
bined and assayed as in tig.1. Saturating concentrations of 
both donor membrane and the various ligands were used: 
(A) activity in the presence of 0.05 mM isoproterenol and 0.1 
mM GTP; (B) assay in the presence of 10 mM sodium fluo- 
ride; (C) assay in the presence of 0.05 mM isoproterenol and 
0.1 mM Gpp(NH)p; (0) activity of the turkey erythrocyte 
membrane alone; (0) activity of the turkey erythrocyte com- 
bined with the human erythrocyte membrane. 
human erythrocyte membrane. The question of the 
stoichiometry of the turkey erythrocyte system can be 
analyzed by extending the experiments outlined earlier 
to include ligands which activate the acceptor turkey 
erythrocyte cyclase. These ligands are isoproterenol + 
GTP, fluoride, and isoproterenol t Gpp(NH)p. In none 
of these cases did the addition of a saturating concen- 
tration of human erythrocyte membrane to the accep- 
tor turkey erythrocyte membrane alter the levels of 
activation seen with these ligands for the acceptor 
membrane alone (fig.3). Of particular interest in this 
regard was the inability of the added N unit to im- 
prove the levels of activation with isoproterenol and 
GTP which in the avian erythrocyte systems (in con- 
trast to other cyclase systems) is well below the levels 
of activity seen with either fluoride or isoproterenol 
and GPPW)P. 
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4. Discussion 
This study shows that the catalytic unit in the 
turkey erythrocyte membrane is available for func- 
tional linkage with N component from human eryth- 
rocyte membranes. Although the details of the nature 
of this linkage are unclear, the units interact in a man- 
ner which confers the ability of Gpp(NH)p to stimu- 
late the turkey erythrocyte C unit. We have demon- 
strated, using cholera toxin treatment, that the linkage 
is through the exogenously added N component. 
The maximal extent of the activation by the donor 
N unit under optimal conditions is much less than the 
activity observed in the presence of hormone. Two 
possible explanations for this difference are: 
(1) Compared to cyc-, the turkey erythrocyte C unit 
may exhibit a different geometry which makes it 
less accessible to the donor N unit. That is, if 
the C unit is already linked to the endogenous N 
component, the donor N would be incapable of 
full activation. Alternatively, the vesicles obtained 
from lysis of the turkey erythrocytes may exhibit 
‘sidedness’, making the C units less available for 
interaction with the donor N component. A com- 
parison of the results in [7] using detergent in 
complementation studies, with those in [lo] 
where it was not, suggests that one role for the 
detergent may be to loosen the membrane or- 
ganization and enhance subunit interaction. The 
studies presented here clearly required a minimal- 
ly perturbed system - therefore, no detergent 
was used. 
(2) The C unit may exist in multiple forms of which 
only a fraction would be available for interacting 
with endogenous or exogenous N units. If all the 
C units are located in NC complexes, then it 
would follow that the C unit is multivalent, i.e., 
capable of accepting more than one N unit. An 
obligatory role for such multivalent complexes in 
the functioning of the adenylate cyclase systems 
has been proposed in [ 17,181. 
A most interesting result was that the exogenous N 
unit did not influence the ability of the adrenergic re- 
ceptor to modify the endogenous N unit. If the recep- 
tor were uncoupled from N, this result is not expect- 
ed. However, this result is consistent with recent 
target size analysis studies which suggest hat the p- 
adrenergic receptor is prelinked to the N and C com- 
ponents in the turkey erythrocyte membrane adenyl- 
ate cyclase [ 191. If the endogenous N and R are in- 
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deed precoupled, no effect of added N on stimulation 
by isoproterenol plus GTP would be expected - as is 
indeed the case. Thus, the inability of exogenous N to 
modify the hormone-promoted exchange of tightly- 
bound GDP with free Gpp(NH)p becomes understand- 
able in terms of the structure of the enzyme. 
These studies also address the stoichiometry of N 
relative to C in the acceptor, turkey erythrocyte mem- 
brane. Several ines of experimentation have demon- 
strated that the fluoride response requires the presence 
of both the N and the C units assembled in a structur- 
ally linked complex [1,2,10,19,20]. The relative stoi- 
chiometry between these units can therefore be probed 
by examining the level of the fluoride response under 
conditions where the N unit is known to functional- 
ly link with C. Thus if N < C, then the addition of 
exogenous N would lead to an enhancement of the 
fluoride response. However, as shown in fig.3 there is 
no enhancement of the fluoride response. Thus the 
turkey erythrocyte adenylate cyclase system must 
contain sufficient N units to couple with all available 
C units. 
The relative amounts of N component and C unit 
in the turkey erythrocyte was also approached from a 
consideration of the role of guanine nucleotide ex- 
change in activation of the enzyme. We have shown 
that a good functional test of the level of GDP binding 
in the turkey erythrocyte adenylate cyclase is the de- 
gree of activation observed with Gpp(NH)p relative to 
that observed with isoproterenol and Gpp(NH)p [6]. 
As shown in fig.l,2 and table 1, the added level of 
activation achieved with Gpp(NH)p is a result of cou- 
pling of exogenous N unit with acceptor C and not 
due to a repair of the endogenous N unit. Maximal 
activation in the acceptor system still required the pres- 
ence of hormone (fig.3). As the level of activation 
with isoproterenol and Gpp(NH)p is neither enhanced 
nor impaired by the addition of the exogenous N unit, 
one would conclude that neither the tight binding of 
GDP nor promotion of its exchange with Gpp(NH)p 
is influenced by the addition of exogenous N unit. It 
also follows that the level of activation with isoproter- 
enol and GTP should be unaltered by this addition. 
These types of experiments are useful in deter- 
mining the functional stoichiometry of adenylate 
cyclase systems, can monitor structural features of 
the enzyme in its membrane bound form, and also al- 
low for the separation of events at the catalytic unit 
from events between the unit and receptor in the ac- 
ceptor system. 
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